RECURRENT PRIMARY PERITONEAL CANCER
Clinical trials for RECURRENT PRIMARY PERITONEAL CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT PRIMARY PERITONEAL CANCER trials appear
Sign up with your email to follow new studies for RECURRENT PRIMARY PERITONEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo takes on recurrent ovarian cancer
Disease control Recruiting nowThis study tests a new drug called ubamatamab, alone or with another drug (cemiplimab), in people with ovarian or uterine cancer that has come back. The main goals are to check safety, find the best dose, and see if the drugs can shrink tumors. About 890 participants will take pa…
Matched conditions: RECURRENT PRIMARY PERITONEAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 22, 2026 12:04 UTC
-
Can ashwagandha boost chemo in ovarian cancer? new trial aims to find out
Disease control Recruiting nowThis study tests adding Ashwagandha (an herbal supplement) to standard chemotherapy (DOXIL) for people whose ovarian cancer has returned. The goal is to find a safe dose and see if the combination helps shrink tumors or slow cancer growth. About 72 participants with recurrent ova…
Matched conditions: RECURRENT PRIMARY PERITONEAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Sham Sunder Kakar • Aim: Disease control
Last updated Jun 18, 2026 11:53 UTC